CDH1 and tumor of parathyroid gland: Among 107 patients in this cohort, negative parafibromin expression in parathyroid neoplasms was significantly associated with overexpression of Ki-67, galectin-3, and PGP9.5, while E-cadherin staining loss was independent of other biomarkers (Fig. 2).